Prevention of febrile leucopenia after chemotherapy in high-risk breast cancer patients: no significant difference between granulocyte-colony stimulating growth factor or ciprofloxacin plus amphotericin B.
暂无分享,去创建一个
N. Mulder | E. de Vries | W. T. van der Graaf | D. Sleijfer | P. Willemse | G. Hospers | C. Schröder | W. V. D. van der Graaf | N. Mulder | W. V. D. Graaf | Carolina P. Schröder | E. D. Vries | D. Sleijfer | Phb Willemse
[1] J. Armitage,et al. 2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] T. Habermann,et al. Granulocyte colony-stimulating factor in severe chemotherapy-induced afebrile neutropenia. , 1997, The New England journal of medicine.
[3] M. Piccart,et al. Consensus on the use of neutrophil-stimulating hematopoietic growth factors in clinical practice: an international viewpoint. , 1997, International journal of antimicrobial agents.
[4] J. Klastersky. Prevention of infection in neutropenic cancer patients. , 1996, Current opinion in oncology.
[5] H. Keizer,et al. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia. , 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[6] L. Twiggs,et al. Chemoprophylaxis with oral ciprofloxacin in ovarian cancer patients receiving taxol. , 1994, Gynecologic oncology.
[7] K. Gelmon,et al. Phase I trial of recombinant human granulocyte-macrophage colony-stimulating factor derived from yeast in patients with breast cancer receiving cyclophosphamide, doxorubicin, and fluorouracil. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[8] M. Palmer,et al. WHO Handbook for Reporting Results of Cancer Treatment , 1982, British Journal of Cancer.